Mahamaya Lifesciences opened lower at ₹178.15, compared with its previous close of ₹181.90. In the last trading session on 12 Nov 2026, the stock traded between ₹175.55 and ₹181.00, with an average traded price of ₹178.74. It showed a downward intraday trend.
An investment of ₹10,000 made 1 year ago in Mahamaya Lifesciences is now worth
₹ 15,517.00
Giving a profit of
₹ 5,517.00 (55.17%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-1.90 (-1.04%)
Day High
₹181.00
Day Low
₹175.55
Day Open
₹178.15
Prev Close
₹181.90
Volume
19,200
Value Traded
₹0.34 Cr
1W Return
-0.55%
1M Return
2.65%
3M Return
-2.96%
6M Return
0.36%
1Y Return
55.17%
Market Cap (₹ Cr.)
421
PE Ratio
25.80
PB Ratio
3.49
Dividend Yield
-
ROE
13.55%
ROCE
25.18%
Book Value (₹)
52.10
Face Value (₹)
10.00
EPS (TTM)
3.04
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.55%
6 Weeks
-
1 Month
2.65%
3 Months
-2.96%
9 Months
-0.28%
Mahamaya Lifesciences FY26 revenue up 24.5% to ₹328.87 crore
Revenue grew 24.5% YoY to ₹328.87 crore in FY26. EBITDA rose 32.6% to ₹34.26 crore, outpacing revenue growth. Net debt-to-equity ratio improved from 1.18x to 0.74x. Dahej technical facility production targeted for 2027.
1mo agoMahamaya Lifesciences shareholders approve leadership reshuffle and board appointments
All nine resolutions passed with 100% majority at the 24th AGM held on September 29, 2026. Krishnamurthy Ganesan re-designated as Chairman; Prashant Krishnamurthy appointed Managing Director. Dr. Bhagirath Choudhary regularized as Independent Director for a three-year term starting August 25, 2026. Promoters abstained from voting on related-party resolutions, relying on public shareholder approval.
1mo agoMahamaya Lifesciences sets AGM date; board reshuffles top roles
Mahamaya Lifesciences AGM scheduled for September 29, 2026, via video conferencing. Mr. Krishnamurthy Ganesan to become Chairman; Mr. Prashant Krishnamurthy to become MD. New annual gross salaries set at ₹1.2 crore for MD and ₹1 crore for Chairman. Revenue grew to ₹32,887.30 lakh in FY26; PAT rose to ₹1,652.33 lakh. Shareholders to approve re-appointment of independent directors including one over 75.
2mo agoMahamaya Lifesciences FY26 Results: Net profit up 29% to ₹16.52 crore
Revenue from operations rose 24.5% YoY to ₹328.87 crore in FY26. Consolidated PAT increased 29.0% to ₹16.52 crore, up from ₹12.81 crore. EBITDA margin expanded to 10.42% from 9.78%, reflecting operational leverage. IPO proceeds strengthened balance sheet, reducing debt-to-equity to 0.74x.
2mo agoMahamaya Lifesciences approves AGM, redesignates Prashant Krishnamurthy as MD
Mahamaya Lifesciences scheduled its 24th AGM for September 29, 2026. Prashant Krishnamurthy redesignated as Managing Director from November 1, 2026. Amarendra Mohapatra appointed as new CFO replacing Prashant Krishnamurthy. Krishnamurthy Ganesan moves from Managing Director to Chairman role. New auditors appointed for FY27 including HPN & Associates and Chandramouli LLP.
2mo agoMahamaya Lifesciences shares investor presentation ahead of Aug 7 meet
Mahamaya Lifesciences Limited has uploaded its investor presentation to its website ahead of the scheduled virtual investor meet on August 07, 2026. The company emphasized that no unpublished price-sensitive information will be shared during the event.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,947.10 | -2.25% | ₹57,451.31 | 38.60 | -10.88% | |
| ₹790.95 | -1.37% | ₹51,180.16 | -488.60 | -11.58% | |
| ₹549.20 | -1.21% | ₹46,361.78 | 21.60 | -27.79% | |
| ₹1,726.00 | -0.82% | ₹26,186.55 | 30.10 | -51.91% | |
| ₹351.10 | -1.56% | ₹17,525.01 | 31.80 | -26.19% | |
| ₹384.70 | -0.48% | ₹15,413.09 | 8.10 | -17.55% | |
| ₹3,425.00 | -1.40% | ₹15,392.67 | 20.90 | -23.99% | |
| ₹141.19 | -1.86% | ₹14,662.87 | 17.50 | -12.27% | |
| ₹663.60 | -0.98% | ₹11,809.14 | 9.70 | -36.64% | |
| ₹195.72 | +1.28% | ₹8,980.76 | 57.20 | +137.21% | |
| ₹245.71 | +1.47% | ₹7,595.83 | 38.10 | +132.20% | |
| ₹729.45 | -1.73% | ₹6,581.13 | 10.40 | -4.22% |
An investment of ₹10,000 made 1 year ago in Mahamaya Lifesciences is now worth
₹ 15,517.00
Giving a profit of
₹ 5,517.00 (55.17%)
Note: Past profits do not guarantee future returns.
